Breaking News Instant updates and real-time market news.

DNB

Dun & Bradstreet

$26.98 /

+0.35 (+1.31%)

07:56
08/06/20
08/06
07:56
08/06/20
07:56

Dun & Bradstreet reports Q2 adj. EPS 26c, consensus 21c

Reports Q2 revenue $420.6M, consensus $416.9M. Dun & Bradstreet CEO Anthony Jabbour said, "Our performance for the quarter was in line with expectations and we continue to make significant progress in our transformation that ultimately supports our long-term strategic goals. Despite a challenging macro-economic environment, our core business fundamentals remained strong and we continue to be uniquely positioned to support our customers through these difficult times."

  • 06

    Aug

  • 01

    Jul

DNB Dun & Bradstreet
$26.98 /

+0.35 (+1.31%)

07/28/20 Citi
Dun & Bradstreet initiated with a Neutral at Citi
07/27/20 JPMorgan
Dun & Bradstreet initiated with a Neutral at JPMorgan
07/27/20 Wells Fargo
Dun & Bradstreet initiated with an Equal Weight at Wells Fargo
07/27/20 Deutsche Bank
Dun & Bradstreet initiated with a Buy at Deutsche Bank

TODAY'S FREE FLY STORIES

Upgrade
Informa upgraded to Buy from Add at Peel Hunt » 05:09
09/23/20
09/23
05:09
09/23/20
05:09
IFJPY

Informa

$0.00 /

+ (+0.00%)

Peel Hunt analyst Malcolm…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IFJPY Informa
$0.00 /

+ (+0.00%)

09/22/20 Credit Suisse
Informa price target lowered to 505 GBp from 550 GBp at Credit Suisse
09/22/20 UBS
Informa price target lowered to 550 GBp from 600 GBp at UBS
09/22/20 Barclays
Informa price target lowered to 465 GBp from 500 GBp at Barclays
09/18/20 UBS
Informa price target lowered to 600 GBp from 620 GBp at UBS
Initiation
Aryzta initiated with a Reduce at Kepler Cheuvreux » 05:09
09/23/20
09/23
05:09
09/23/20
05:09
ARZTY

Aryzta

$0.00 /

+ (+0.00%)

Kepler Cheuvreux…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ARZTY Aryzta
$0.00 /

+ (+0.00%)

06/01/20 UBS
Aryzta price target lowered to CHF 0.65 from CHF 0.95 at UBS
ARZTY Aryzta
$0.00 /

+ (+0.00%)

Upgrade
Hargreaves Lansdown upgraded to Buy from Hold at Liberum » 05:08
09/23/20
09/23
05:08
09/23/20
05:08
HRGLY

Hargreaves Lansdown

$0.00 /

+ (+0.00%)

Liberum analyst Rahim…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HRGLY Hargreaves Lansdown
$0.00 /

+ (+0.00%)

09/10/20 Deutsche Bank
Hargreaves Lansdown upgraded to Hold from Sell at Deutsche Bank
09/08/20 Berenberg
Hargreaves Lansdown upgraded to Buy from Hold at Berenberg
09/02/20 Morgan Stanley
Hargreaves Lansdown price target raised to 1,470 GBp at Morgan Stanley
09/01/20 Jefferies
Hargreaves Lansdown upgraded to Hold from Underperform at Jefferies
Downgrade
Autoliv downgraded to Neutral from Outperform at Exane BNP Paribas » 05:07
09/23/20
09/23
05:07
09/23/20
05:07
ALV

Autoliv

$71.63 /

+0.38 (+0.53%)

Exane BNP Paribas analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALV Autoliv
$71.63 /

+0.38 (+0.53%)

ALV Autoliv
$71.63 /

+0.38 (+0.53%)

09/03/20
Fly Intel: Top five analyst downgrades
09/03/20 Kepler Cheuvreux
Autoliv downgraded to Hold from Buy at Kepler Cheuvreux
07/20/20 RBC Capital
Autoliv price target raised to $80 from $77 at RBC Capital
07/20/20 Mizuho
Autoliv price target raised to $72 from $70 at Mizuho
ALV Autoliv
$71.63 /

+0.38 (+0.53%)

ALV Autoliv
$71.63 /

+0.38 (+0.53%)

Hot Stocks
Best Inc., Cainiao Network launch logistics service between China and Malaysia » 05:06
09/23/20
09/23
05:06
09/23/20
05:06
BEST

Best Inc.

$3.22 /

+0.205 (+6.80%)

Best Inc., together with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BEST Best Inc.
$3.22 /

+0.205 (+6.80%)

BEST Best Inc.
$3.22 /

+0.205 (+6.80%)

05/15/20
Fly Intel: Top five analyst downgrades
05/15/20 Macquarie
Best Inc. downgraded to Neutral from Outperform at Macquarie
03/02/20 Oppenheimer
Best Inc. assumed with an Outperform at Oppenheimer
12/05/19 Jefferies
Best Inc. initiated with a Buy at Jefferies
BEST Best Inc.
$3.22 /

+0.205 (+6.80%)

BEST Best Inc.
$3.22 /

+0.205 (+6.80%)

Initiation
Nomad Royalty initiated with a Buy at Industrial Alliance » 05:06
09/23/20
09/23
05:06
09/23/20
05:06
NSRXF

Nomad Royalty

$0.00 /

+ (+0.00%)

Industrial Alliance…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Facebook risk/reward 'remains compelling,' says Jefferies » 05:03
09/23/20
09/23
05:03
09/23/20
05:03
FB

Facebook

$254.80 /

+6.71 (+2.70%)

, AAPL

Apple

$111.77 /

+1.64 (+1.49%)

After hosting a call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FB Facebook
$254.80 /

+6.71 (+2.70%)

AAPL Apple
$111.77 /

+1.64 (+1.49%)

FB Facebook
$254.80 /

+6.71 (+2.70%)

09/22/20 Oppenheimer
Facebook price target raised to $300 from $270 at Oppenheimer
09/18/20 Morgan Stanley
Facebook price target raised to $295 from $285 at Morgan Stanley
09/15/20
Fly Intel: Top five analyst initiations
09/14/20 KeyBanc
Facebook initiated with an Overweight at KeyBanc
AAPL Apple
$111.77 /

+1.64 (+1.49%)

09/22/20
UBS assumes Apple with Neutral from Buy amid 'maturing' iPhone growth
09/22/20 UBS
Apple assumed with Neutral from Buy at UBS
09/21/20 Citi
Apple price target raised to $125 from $112.50 at Citi
09/18/20 JPMorgan
Apple Fitness+ contribution will take time, says JPMorgan
FB Facebook
$254.80 /

+6.71 (+2.70%)

AAPL Apple
$111.77 /

+1.64 (+1.49%)

FB Facebook
$254.80 /

+6.71 (+2.70%)

AAPL Apple
$111.77 /

+1.64 (+1.49%)

FB Facebook
$254.80 /

+6.71 (+2.70%)

AAPL Apple
$111.77 /

+1.64 (+1.49%)

FB Facebook
$254.80 /

+6.71 (+2.70%)

AAPL Apple
$111.77 /

+1.64 (+1.49%)

AAPL Apple
$111.77 /

+1.64 (+1.49%)

Initiation
Cornerstone OnDemand initiated with a Market Perform at BMO Capital » 04:59
09/23/20
09/23
04:59
09/23/20
04:59
CSOD

Cornerstone OnDemand

$34.69 /

+0.27 (+0.78%)

BMO Capital analyst Keith…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CSOD Cornerstone OnDemand
$34.69 /

+0.27 (+0.78%)

CSOD Cornerstone OnDemand
$34.69 /

+0.27 (+0.78%)

07/27/20
Fly Intel: Top five analyst downgrades
07/27/20 BofA
Cornerstone OnDemand double-downgraded to Underperform from Buy at BofA
07/27/20 BofA
Cornerstone OnDemand downgraded to Underperform from Buy at BofA
06/29/20 Goldman Sachs
Cornerstone OnDemand price target raised to $46 from $37 at Goldman Sachs
CSOD Cornerstone OnDemand
$34.69 /

+0.27 (+0.78%)

Recommendations
Nike price target raised to $140 from $137 at Pivotal Research » 04:57
09/23/20
09/23
04:57
09/23/20
04:57
NKE

Nike

$116.98 /

+3.67 (+3.24%)

Pivotal Research analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NKE Nike
$116.98 /

+3.67 (+3.24%)

NKE Nike
$116.98 /

+3.67 (+3.24%)

09/22/20 Baird
Nike price target raised to $115 but limited upside seen, says Baird
09/18/20 Needham
Nike price target raised to $132 from $113 at Needham
09/18/20 Morgan Stanley
Nike price target raised to $142 from $121 at Morgan Stanley
09/18/20 Raymond James
Nike price target raised to $121 from $115 at Raymond James
NKE Nike
$116.98 /

+3.67 (+3.24%)

NKE Nike
$116.98 /

+3.67 (+3.24%)

NKE Nike
$116.98 /

+3.67 (+3.24%)

NKE Nike
$116.98 /

+3.67 (+3.24%)

Upgrade
Twitter upgraded to Buy from Hold at Pivotal Research » 04:55
09/23/20
09/23
04:55
09/23/20
04:55
TWTR

Twitter

$42.73 /

+2.84 (+7.12%)

Pivotal Research analyst…

Pivotal Research analyst Michael Levine upgraded Twitter to Buy from Hold with a price target of $59.75, up from $36. The stock closed Tuesday up $2.83 to $42.73. The analyst likes the Olympics coming in 2021, direct response beginning to kick in, and Twitter's potential subscription business. The company's Q3 earnings report and forward commentary are likely to act as positive catalysts for the stock, Levine tells investors in a research note. In addition, investor sentiment is "by far the most negative in our coverage" and as a result, the "rubber band for stock out-performance the greatest," says the analyst. Levine believes the changes Twitter has made around the process of onboarding new users over the last few months has meaningfully improved.

ShowHide Related Items >><<
TWTR Twitter
$42.73 /

+2.84 (+7.12%)

TWTR Twitter
$42.73 /

+2.84 (+7.12%)

09/15/20
Fly Intel: Top five analyst initiations
09/14/20 KeyBanc
Twitter initiated with a Sector Weight at KeyBanc
09/14/20 KeyBanc
Twitter initiated with a Sector Weight at KeyBanc
09/03/20 Cleveland Research
Twitter pace of recovery looks slower than peers, says Cleveland Research
TWTR Twitter
$42.73 /

+2.84 (+7.12%)

TWTR Twitter
$42.73 /

+2.84 (+7.12%)

TWTR Twitter
$42.73 /

+2.84 (+7.12%)

TWTR Twitter
$42.73 /

+2.84 (+7.12%)

Conference/Events
UBS technology analyst to hold an analyst/industry conference call » 04:55
09/23/20
09/23
04:55
09/23/20
04:55

Technology Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
UBS healthcare analysts to hold an analyst/industry conference call » 04:55
09/23/20
09/23
04:55
09/23/20
04:55

Healthcare Analysts Mayo,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Assured Guaranty participates in a conference call hosted by MKM Partners » 04:55
09/23/20
09/23
04:55
09/23/20
04:55
AGO

Assured Guaranty

$19.33 /

+0.125 (+0.65%)

MKM Partners host…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AGO Assured Guaranty
$19.33 /

+0.125 (+0.65%)

08/07/20 MKM Partners
Assured Guaranty price target lowered to $45 from $65 at MKM Partners
AGO Assured Guaranty
$19.33 /

+0.125 (+0.65%)

Conference/Events
Gibraltar Industries management to meet virtually with KeyBancc » 04:55
09/23/20
09/23
04:55
09/23/20
04:55
ROCK

Gibraltar Industries

$62.07 /

+0.26 (+0.42%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ROCK Gibraltar Industries
$62.07 /

+0.26 (+0.42%)

ROCK Gibraltar Industries
$62.07 /

+0.26 (+0.42%)

05/07/20 KeyBanc
Gibraltar Industries price target lowered to $55 from $60 at KeyBanc
03/23/20 Sidoti
Gibraltar Industries upgraded to Buy from Neutral at Sidoti
ROCK Gibraltar Industries
$62.07 /

+0.26 (+0.42%)

Conference/Events
Ellington Financial management to meet virtually with JMP Securities » 04:55
09/23/20
09/23
04:55
09/23/20
04:55
EFC

Ellington Financial

$12.57 /

+0.1 (+0.80%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
EFC Ellington Financial
$12.57 /

+0.1 (+0.80%)

EFC Ellington Financial
$12.57 /

+0.1 (+0.80%)

07/13/20 BofA
Ellington Financial initiated with a Neutral at BofA
07/13/20 BofA
Ellington Financial initiated with a Neutral at BofA
04/09/20 Piper Sandler
Mortgage Finance volatility brings 'unique opportunity,' says Piper Sandler
09/27/19 Nomura Instinet
Ellington Financial initiated with a Buy at Nomura Instinet
EFC Ellington Financial
$12.57 /

+0.1 (+0.80%)

  • 22
    Jan
  • 19
    Nov
General news
Federal Reserve Vice Chair for Supervision Randal Quarles Speech to be released at 00:00  04:55
09/23/20
09/23
04:55
09/23/20
04:55
 
General news
Chicago Federal Reserve Bank President Charles Evans Speech to be released at 11:00  04:55
09/23/20
09/23
04:55
09/23/20
04:55
 
General news
Week of 9/18 MBA Mortgage Applications to be released at 07:00  04:55
09/23/20
09/23
04:55
09/23/20
04:55
 
Conference/Events
Goldman Sachs to hold a virtual conference » 04:55
09/23/20
09/23
04:55
09/23/20
04:55
LLY

Eli Lilly

$149.93 /

-1.3 (-0.86%)

, MRNA

Moderna

$68.73 /

-0.58 (-0.84%)

, GS

Goldman Sachs

$191.64 /

-2.37 (-1.22%)

Next Phase of Healthcare,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

ShowHide Related Items >><<
LLY Eli Lilly
$149.93 /

-1.3 (-0.86%)

MRNA Moderna
$68.73 /

-0.58 (-0.84%)

GS Goldman Sachs
$191.64 /

-2.37 (-1.22%)

LLY Eli Lilly
$149.93 /

-1.3 (-0.86%)

09/21/20 Morgan Stanley
Eli Lilly's Verzenio 'clear winner' over Pfizer's Ibrance, says Morgan Stanley
09/16/20 Canaccord
Eli Lilly COVID-19 data bodes well for Regeneron, says Canaccord
09/16/20 Goldman Sachs
Eli Lilly COVID-19 antibody data 'encouraging,' says Goldman Sachs
09/07/20 Piper Sandler
Early approval of Blueprint's Gavreto 'a nice surprise,' says Piper Sandler
MRNA Moderna
$68.73 /

-0.58 (-0.84%)

09/18/20 Needham
Moderna shares attractive long term on mRNA platform and pipeline, says Needham
09/17/20 Jefferies
Moderna COVID trial stats suggest late Oct. or Nov. for data, says Jefferies
09/09/20 SVB Leerink
AstraZeneca pause 'a mixed blessing for Moderna, others, says SVB Leerink
09/08/20
Fly Intel: Top five analyst downgrades
GS Goldman Sachs
$191.64 /

-2.37 (-1.22%)

08/06/20 Piper Sandler
Now is the time to buy Goldman Sachs, says Piper Sandler
07/20/20 Berenberg
Goldman Sachs price target raised to $200 from $160 at Berenberg
07/16/20 DA Davidson
Goldman Sachs price target raised to $238 from $215 at DA Davidson
07/16/20 Oppenheimer
Goldman Sachs price target raised to $355 from $335 at Oppenheimer
LLY Eli Lilly
$149.93 /

-1.3 (-0.86%)

MRNA Moderna
$68.73 /

-0.58 (-0.84%)

GS Goldman Sachs
$191.64 /

-2.37 (-1.22%)

  • 19
    May
  • 12
    Feb
LLY Eli Lilly
$149.93 /

-1.3 (-0.86%)

MRNA Moderna
$68.73 /

-0.58 (-0.84%)

GS Goldman Sachs
$191.64 /

-2.37 (-1.22%)

LLY Eli Lilly
$149.93 /

-1.3 (-0.86%)

MRNA Moderna
$68.73 /

-0.58 (-0.84%)

GS Goldman Sachs
$191.64 /

-2.37 (-1.22%)

LLY Eli Lilly
$149.93 /

-1.3 (-0.86%)

MRNA Moderna
$68.73 /

-0.58 (-0.84%)

GS Goldman Sachs
$191.64 /

-2.37 (-1.22%)

Conference/Events
UBS leisure, gaming & lodging analyst to hold analyst/industry conference call » 04:55
09/23/20
09/23
04:55
09/23/20
04:55

Leisure, Gaming &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Sykes Enterprises management to meet virtually with Barrington » 04:55
09/23/20
09/23
04:55
09/23/20
04:55
SYKE

Sykes Enterprises

$32.94 /

+1.39 (+4.41%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SYKE Sykes Enterprises
$32.94 /

+1.39 (+4.41%)

09/22/20 Baird
Sykes Enterprises desiganted as a Fresh Pick at Baird
06/04/20 Baird
Sykes Enterprises upgraded to Outperform at Baird
06/04/20 Baird
Sykes Enterprises upgraded to Outperform from Neutral at Baird
03/16/20 Sidoti
Sykes Enterprises upgraded to Buy from Neutral at Sidoti
SYKE Sykes Enterprises
$32.94 /

+1.39 (+4.41%)

SYKE Sykes Enterprises
$32.94 /

+1.39 (+4.41%)

Conference/Events
Nutanix management to meet virtually with KeyBanc » 04:55
09/23/20
09/23
04:55
09/23/20
04:55
NTNX

Nutanix

$22.70 /

+1.06 (+4.90%)

Virtual Meeting to be…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTNX Nutanix
$22.70 /

+1.06 (+4.90%)

NTNX Nutanix
$22.70 /

+1.06 (+4.90%)

08/28/20
Fly Intel: Top five analyst downgrades
08/28/20 Stifel
Nutanix model shift impacts may not be fully appreciated, says Stifel
08/28/20 Baird
Nutanix downgraded to Neutral from Outperform at Baird
08/21/20 Cleveland Research
Nutanix estimates at risk over next several quarters, says Cleveland Research
NTNX Nutanix
$22.70 /

+1.06 (+4.90%)

NTNX Nutanix
$22.70 /

+1.06 (+4.90%)

NTNX Nutanix
$22.70 /

+1.06 (+4.90%)

NTNX Nutanix
$22.70 /

+1.06 (+4.90%)

Conference/Events
Cardiff Oncology to hold a KOL conference call » 04:55
09/23/20
09/23
04:55
09/23/20
04:55
CRDF

Cardiff Oncology

$11.67 /

+0.1 (+0.86%)

Management holds a Key…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRDF Cardiff Oncology
$11.67 /

+0.1 (+0.86%)

CRDF Cardiff Oncology
$11.67 /

+0.1 (+0.86%)

09/18/20 Maxim
Cardiff Oncology price target raised to $14 from $6 at Maxim
CRDF Cardiff Oncology
$11.67 /

+0.1 (+0.86%)

Conference/Events
Goldman Sachs to hold a virtual conference » 04:55
09/23/20
09/23
04:55
09/23/20
04:55

9th German Corporate…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 8 minutes

Get Free Trial

Conference/Events
Wabtec participates in a conference call hosted by Stephens » 04:55
09/23/20
09/23
04:55
09/23/20
04:55
WAB

Wabtec

$62.20 /

-0.79 (-1.25%)

Stephens Managing…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WAB Wabtec
$62.20 /

-0.79 (-1.25%)

WAB Wabtec
$62.20 /

-0.79 (-1.25%)

07/29/20 Wells Fargo
Wabtec price target raised to $80 from $75 at Wells Fargo
07/29/20 Citi
Wabtec price target raised to $70 from $60 at Citi
07/07/20 Wolfe Research
Wabtec downgraded to Underperform from Peer Perform at Wolfe Research
06/03/20
Fly Intel: Top five analyst downgrades
WAB Wabtec
$62.20 /

-0.79 (-1.25%)

WAB Wabtec
$62.20 /

-0.79 (-1.25%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.